UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000530
Receipt number R000000641
Scientific Title A Randomized Investigation of Short-term Prognosis and Costs and Long-term Prognosis of Medical vs. Coronary Intervention for Low-risk Stable Effort Angina
Date of disclosure of the study information 2006/11/27
Last modified on 2006/11/27 21:18:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized Investigation of Short-term Prognosis and Costs and Long-term Prognosis of Medical vs. Coronary Intervention for Low-risk Stable Effort Angina

Acronym

Japanese Stable Angina Pectoris Study (JSAP Study)

Scientific Title

A Randomized Investigation of Short-term Prognosis and Costs and Long-term Prognosis of Medical vs. Coronary Intervention for Low-risk Stable Effort Angina

Scientific Title:Acronym

Japanese Stable Angina Pectoris Study (JSAP Study)

Region

Japan


Condition

Condition

low-risk stable effort angina

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine which of medical therapy and coronary intervention as the initial treatment is better for patients with low-risk stable effort angina indicated for intervention at the viewpoint of the short-term and long-term prognoses of intervention and its costs during the initial 1 year.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

death (total death, cardiac death, sudden death), acute coronary syndrome (Q-wave infarction, non-Q wave infarction, unstable angina pectoris), and cerebrovascular diseases such as cerebral infarction and cerebral hemorrhage

Key secondary outcomes

angina pectoris classification and evaluation of survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation

YES

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

medical therapy as the initial treatment

Interventions/Control_2

coronary intervention as the initial treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

low-risk stable effort angina indicating 1-vessel or 2-vessel disease without stenotic lesions in LMT or the ostial leasion in LAD (within 5 mm from the bifurcation) in whom CAG shows significant stenosis in the culprit lesion, and PCI/CABG is indicated

Key exclusion criteria

1) Lesions in LMT or at the ostial site of LAD (within 5 mm from bifurcation)
2) 3-vessel disease
3) 2-vessel chronic total obstruction
4) 1-vessel chronic complete obstruction for which the possibility of PCI success is low (long-term chronic complete obstruction, long complete obstruction lesions)
5) Acute myocardial infarction
6) Ejection fraction of left ventricle less than 50%
7) Lesions not indicated for PCI/CABG (thin lateral branches, peripheral branches)
8) Complications such as bleeding tendency, DIC, and severe pneumonia
9) Impaired renal function (Cr > 1.5 mg/dl)
10) Patients with severe ASO and aneurysms not indicated for PCI/CABG
11) Patients with asymptomatic myocardial ischemia not complicated by effort angina pectoris
12) Patients with unstable angina pectoris who newly developed symptoms or showed aggravation within 6 weeks
13) CABG patients with graft stenosis as a responsible lesion

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisayoshi Fujiwara, MD

Organization

Gifu University Graduate School of Medicine

Division name

Second Department of Internal Medicine

Zip code


Address

Yanagido 1-1, Gifu City, Gifu, JAPAN

TEL

058-230-6523

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kazuhiko Nishigaki, MD

Organization

Gifu University Graduate School of Medicine

Division name

Second Department of Internal Medicine

Zip code


Address

Yanagido 1-1, Gifu City, Gifu, JAPAN

TEL

058-230-6523

Homepage URL

http://poppy.ac/jsap/

Email

nissy@gifu-u.ac.jp


Sponsor or person

Institute

The JSAP Study Investigators

Institute

Department

Personal name



Funding Source

Organization

Health and Labour Sciences Research Grant (Clinical Research for Evidence Based Medicine) from the Japanese Ministry of Health, Labour and Welfare
Japan Heart Foundation

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 11 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2002 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2002 Year 02 Month 01 Day

Last follow-up date

2006 Year 05 Month 01 Day

Date of closure to data entry

2007 Year 01 Month 01 Day

Date trial data considered complete

2007 Year 02 Month 01 Day

Date analysis concluded

2007 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 11 Month 27 Day

Last modified on

2006 Year 11 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000641


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name